Vaxcyte, Inc.
PCVX
Classifica tra le azioni
#2023
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage,... Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.
Prezzo delle azioni
$66.75
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$10.24B
Variazione (1 giorno)
4.81%
Variazione (1 anno)
57.60%
Paese
US
Scambia Vaxcyte, Inc. (PCVX)
Categoria
Healthcare
Storico del prezzo dell'azione per Vaxcyte, Inc. (PCVX)
Prezzo di chiusura più alto: $65.77 il 2026-10-01
Prezzo di chiusura più basso: $32.16 il 2020-06-01
Prezzo di chiusura più basso: $32.16 il 2020-06-01
Storico del prezzo dell'azione di Vaxcyte, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | 18.76% |
| 2025 | -48.18% |
| 2024 | 49.19% |
| 2023 | 30.50% |
| 2022 | 103.95% |
| 2021 | -26.14% |
| 2020 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $514.04 | 20.59% |
US
|
|
| $241.53 | 778.61% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $804.01 | 14.70% |
CH
|
|
| $875.26 | 4.85% |
NL
|
